Correlation Between Arcus Biosciences and Agios Pharm

Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arcus Biosciences and Agios Pharm, you can compare the effects of market volatilities on Arcus Biosciences and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and Agios Pharm.

Diversification Opportunities for Arcus Biosciences and Agios Pharm

-0.16

Correlation Coefficient

Arcus Biosciences  Agios Pharm

Good diversification

The 3 months correlation between Arcus and Agios is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and Agios Pharm go up and down completely randomly.

Pair Corralation between Arcus Biosciences and Agios Pharm

Given the investment horizon of 90 days Arcus Biosciences is expected to generate 0.78 times more return on investment than Agios Pharm. However, Arcus Biosciences is 1.28 times less risky than Agios Pharm. It trades about 0.01 of its potential returns per unit of risk. Agios Pharm is currently generating about -0.06 per unit of risk. If you would invest  1,571  in Arcus Biosciences on September 23, 2024 and sell it today you would lose (21.00) from holding Arcus Biosciences or give up 1.34% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Arcus Biosciences  vs.  Agios Pharm

Arcus Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Arcus Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Arcus Biosciences is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Agios Pharm

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Agios Pharm has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Arcus Biosciences and Agios Pharm

The main advantage of trading using opposite Arcus Biosciences and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.

The idea behind Arcus Biosciences and Agios Pharm pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.